Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 261-267, February 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davidson, J. D.
Right arrow Articles by Winter, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davidson, J. D.
Right arrow Articles by Winter, T. S.

Purine Nucleotide Pyrophosphorylases in 6-Mercaptopurine-sensitive and -resistant Human Leukemias*

Jack D. Davidson and Thorne S. Winter{dagger}

( Clinical Pharmacology and Experimental Therapeutics Service, Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland)

The present study was undertaken to determine whether a loss of the enzyme activity responsible for converting 6-mercaptopurine, hypoxanthine, and guanine to their ribonucleotides correlates with resistance to 6-mercaptopurine in human leukemic leukocytes. Six normal and 26 leukemic patients were studied. Fifteen of the leukemic patients were felt to be clinically resistant to 6-mercaptopurine. Only one of these showed a significant reduction in inosinic-guanylic pyrophosphorylase activity. All other leukemic patients showed enzyme activities similar to those of normal patients, except that the leukemic patients had an adenylic pyrophosphorylase activity 2–3 x that of normal leukocytes. Thus, loss of inosinic-guanylic pyrophosphorylase did occur in human leukemia, but it did not explain most cases of resistance to 6-mercaptopurine in the leukemic patients studied.

* Presented in part before the 54th annual meeting of the American Association for Cancer Research, May, 1963, Toronto, Canada, and published in abstract form in Proc. Am. Assoc. Cancer Research, 4: 72, 1963.

{dagger} Present address: Peter Bent Brigham Hospital, Boston, Mass.

Received 7/31/63.


This article has been cited by other articles:


Home page
ScienceHome page
R. J. Albertini and R. DeMars
Diploid Azaguanine-Resistant Mutants of Cultured Human Fibroblasts
Science, July 31, 1970; 169(3944): 482 - 485.
[Abstract] [PDF]


Home page
ScienceHome page
J. E. Seegmiller, F. M. Rosenbloom, and W. N. Kelley
Enzyme Defect Associated with a Sex-Linked Human Neurological Disorder and Excessive Purine Synthesis
Science, March 31, 1967; 155(3770): 1682 - 1684.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.